false
0002032341
0002032341
2026-11-16
2026-11-16
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): November 16, 2026
CYABRA, INC.
(Exact
name of registrant as specified in its charter)
| Delaware | |
001-43214 | |
99-4210757 |
(State or other jurisdiction
of Incorporation) | |
(Commission File Number) | |
(IRS Employer
Identification Number) |
13 Gershon Shatz
Tel Aviv Israel |
|
6997543 |
| (Address of registrant’s principal executive office) |
|
(Zip code) |
+972-54-768-8642
(Registrant’s
telephone number, including area code)
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
symbol(s) |
|
Name
of each exchange on which registered |
| Common Stock, par value $0.0001 per share |
|
CYAB |
|
The Nasdaq Stock Market LLC |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
1.01 Entry into a Material Definitive Agreement
Private
Placement Financing
On
November 15, 2026, Cyabra Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase
Agreement”) with certain institutional investors (the “Purchasers”), pursuant to which the Company agreed to issue
and sell shares of newly to be designated Series D Preferred Stock and warrants to purchase shares of the Company’s common stock
(the “Common Stock”) in a private placement (the “Offering”). The Company intends to use the net proceeds received
from the Offering for working capital and other general corporate purposes.
The
Securities Purchase Agreement contemplates an initial closing with an aggregate subscription amount of $15,610,120, consisting of $10,000,000
of new investment and $5,610,120 of subscription consideration to be satisfied through the cancellation of $2,805,060 of outstanding
indebtedness of the Company. The Series D Preferred Stock has a stated value of $1,000 per share and an initial conversion price of $0.15
per share, subject to adjustment. The warrants have an initial exercise price of $0.15 per share, subject to adjustment, and are exercisable
following the receipt of the required stockholder approval for a period of five years thereafter.
The
initial closing is subject to the satisfaction or waiver of certain conditions set forth in the Purchase Agreement, including applicable
stockholder approvals and conditions relating to the Company’s continued listing on Nasdaq Stock Market LLC (“Nasdaq”).
As of the date of this Current Report on Form 8-K, the initial closing has not occurred, and the Company has not received the proceeds
contemplated by the initial closing. There can be no assurance that the initial closing will occur on the anticipated terms or at all.
The
Securities Purchase Agreement also contemplates additional investments of up to $30,000,000 in tranches of $500,000 each, for a three
year period following the initial closing, subject to the terms and conditions set forth therein, including applicable equity conditions.
There can be no assurance that any such additional investments will be made.
The
Series D Preferred Stock will not have any voting rights. Upon any liquidation, dissolution or winding-up of the Company, after the satisfaction
in full of the debts of the Company and payment of the liquidation preference to any senior securities, holders of Series D Preferred
Stock shall be entitled to be paid, on a pari passu basis with the payment of any liquidation preference afforded to holders of any parity
securities.
In
connection with the Securities Purchase Agreement, the Company entered into a Registration Rights Agreement with the Purchasers, pursuant
to which the Company agreed to register for resale the shares of common stock issuable upon conversion of the Series D Preferred Stock
and exercise of the warrants, subject to the terms and conditions thereof. The Company is required to file such registration statement
within two days following the initial closing of the Offering.
Pursuant
to the terms of the Securities Purchase Agreement, the Company also agreed to consider making certain management changes within ten days
of the initial closing of the Offering, which includes appointment Joe Hayon as President and director, Nir Brenmiller as director and
Roy Hass as Chairman of the Board.
The
securities are being offered and sold in reliance upon an exemption from the registration requirements of the Securities Act of 1933,
as amended, pursuant to Section 4(a)(2) thereof and/or Regulation D thereunder.
The
foregoing descriptions of the Securities Purchase Agreement, the Registration Rights Agreement, the Certificate of Designation of Preferences,
Rights and Limitations of the Series D Preferred Stock and the warrants do not purport to be complete and are qualified in their entirety
by reference to such documents, which are filed as Exhibits 10.1, 10.2, 3.1 and 4.1, respectively, to this this Current Report on Form
8-K and incorporated herein by reference.
Warrant
Amendment
On
November 15, 2026, the Company and the lead investor from the private placement offering conducted in July 2026, entered into a warrant
amendment agreement whereby the Company agreed to reduce the exercise price of the Company’s Series A warrant to purchase up to
8,045,980 shares of Common Stock and the Company’s Series B warrant to purchase up to 8,045,980 shares of Common Stock from $0.50
and $0.45, respectively, to $0.15 per share, as well as including an anti-dilution protection mechanism permitting a one-time reduction
of the exercise price following the Company’s reverse stock split. The investor provided the Company with a waiver of its certain
variable rate transaction restriction to permit the Company to enter into the Securities Purchase Agreement and the Purchase Agreement.
Item
3.02 Unregistered Sales of Equity Securities.
The
response to this item is included in Item 1.01, Entry into a Material Definitive Agreement, and is incorporated herein in its entirety.
Item
8.01 Other Events.
On
November 16, 2026, the Company issued a press release relating to the announcement of the Offering. A copy of the press release is filed
as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Forward-Looking
Statements
Certain
information contained in this report consists of forward-looking statements for purposes of the federal securities law that involve risks,
uncertainties and assumptions that are difficult to predict. Words such as “will,” “would,” “may,”
“intends,” “potential,” and similar expressions, or the use of future tense, identify forward-looking statements,
but their absence does not mean that a statement is not forward-looking. Such forward-looking statements are not guarantees of performance
and actual actions or events could differ materially from those contained in such statements. For example, the Company is using forward-looking
statements when it discusses issuance of securities subject to Stockholder Approval. For additional information about factors that could
cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company’s
filings with the SEC. The forward-looking statements contained in this report speak only as of the date of this report and the Company
undertakes no obligation to publicly update any forward-looking statements to reflect changes in information, events or circumstances
after the date of this report, unless required by law.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits
| 3.1 |
|
Form of Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock |
| 4.1 |
|
Form of Common Warrant |
| 10.1 |
|
Form of Securities Purchase Agreement |
| 10.2 |
|
Form of Registration Rights Agreement |
| 99.1 |
|
Press release dated November 16, 2026 |
| 104 |
|
Cover
Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| Dated:
November 16, 2026 |
CYABRA,
INC. |
| |
|
| |
By: |
/s/
Dan Brahmy |
| |
Name: |
Dan
Brahmy |
| |
Title: |
Chief
Executive Officer |
Exhibit 99.1
Cyabra Announces Pricing of Up to $45 Million
Strategic Investment to Scale Its Sovereign AI Information-Warfare Platform
Initial closing consists of a $15 million investment-
$10 million in cash and an additional $5 million in conversion of outstanding debt
The Company has the opportunity to receive
additional investments of up to $30 million within the next three years
New York, NY, November 16, 2026 (GLOBE
NEWSWIRE) -- Cyabra, Inc. (Nasdaq: CYAB) (“Cyabra” or the “Company”), a provider
of information-warfare technology that helps intelligence agencies and enterprises detect coordinated hostile activity and identify the
networks behind it, today announced an investment agreement with institutional investors for up to $40 million in new investment in the
Company over 3 years and the cancellation of approximately $3 million of outstanding debt.
The investment targets to scale delivery capacity
of the Company’s sovereign information warfare platform, to meet growing demand and support the Company’s long-term milestones.
It is also expected to drive the Company’ growth in leading markets and accelerate the rollout of additional technological capabilities
across Cyabra’s existing product portfolio and expand its reach among U.S. federal agencies, international intelligence organizations,
and fortune 500 enterprise customers. Building on recent multi-year contracts, within ten days of the initial closing, Cyabra intends
to add seasoned public-company executives to its management team and Board to lead commercial expansion and scale the business, subject
to corporate approvals.
The parties have agreed to an initial closing
of a $10 million cash investment in the Company and an additional $5.6 million in conversion of outstanding debt. The agreement also gives
the Company the opportunity to receive up to an additional $30 million within three years of which the Investor has committed, subject
to certain conditions set forth in the purchase agreement, to fund $5 million within the first 12 months after the initial closing date
and another $5 million within the first 18 months after the initial closing date.
The Company has entered into a securities purchase
agreement with institutional investors for the purchase and sale of up to an aggregate of $40 million. The initial closing of $15.6 million
includes issuance of preferred stock, which initially be convertible into shares of common stock at an initial conversion price of $0.15
per share and warrants. The warrants will have an initial exercise date following stockholder approval and will have a term of five years.
The Company has agreed to call a shareholder meeting to approve the issuance of the common stock issuable upon conversion of the preferred
stock and issuable upon exercise of the warrants. The investors will have an additional investment right of up to an additional $30,000,000
over a three-year period in tranches of $500,000. For the initial closing, an aggregate of $15.6 million of the subscription amount represents
a $10 million new cash investment, and $5.6 million represents subscription consideration satisfied by cancellation of $2.8 million of
outstanding debt of the Company.
The initial closing of
the offering is expected to occur on or about December 2026, subject to the satisfaction of customary closing conditions, as well as other
conditions, including the approval of the issuance of the securities at a stockholders meeting and the Company satisfying its continued
listing deficiencies on Nasdaq. The purchase agreement also contemplates the Company entering into a $50 million equity line of credit
(the “ELOC”). The final terms of the ELOC are being negotiated and it is anticipated to be executed together with the
closing of the purchase agreement. The Company currently intends to use the net proceeds from the offering for working capital and other
general corporate purposes. The Company also believes the receipt of the funding from the offering will assist the Company in maintaining
its Nasdaq listing.
Dan Brahmy, Co-Founder and CEO of Cyabra stated.
“This strategic funding, once closed, is expected to provide the balance-sheet strength to scale our information warfare defense
technologies, where global demand for sovereign cognitive defense is surging.”
The offer and sale of the foregoing securities
is being made in reliance on an exemption from the registration requirement under Section 4(a)(2) of the Securities Act of 1933, as amended
(the “Securities Act”), and/or Regulation D promulgated thereunder, and applicable state securities laws, and the securities
have not been and will not initially be registered under the Securities Act, or applicable state securities laws. Accordingly, the securities
may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from
the registration requirements of the Securities Act and such applicable state securities laws. The Company has agreed to file a registration
statement with the U.S. Securities and Exchange Commission (the “SEC”) covering the resale of the shares of common stock issuable
upon conversion of the preferred stock and issuable upon exercise of the warrants.
This press release shall not constitute an offer
to sell or the solicitation of an offer to buy the securities being offered, nor shall there be any sale of these securities in any state
or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities
laws of any such state or jurisdiction.
About Cyabra
Cyabra is a company that builds and deploys information
warfare technologies to defend national security interests and enterprise organizations. Combining advanced AI with defense expertise,
Cyabra identifies coordinated inauthentic activity, exposes influence operations, and delivers actionable intelligence to support national
security and critical decision-making.
For more information, visit
www.cyabra.com.
Contact
Investors:
ir@cyabra.com
Media:
pr@cyabra.com
Forward-Looking Statements
This press release contains forward-looking statements
within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements
that are not historical statements of fact and statements regarding Cyabra’s intent, belief, or expectations, including, but not limited
to, statements regarding Cyabra’s future results of operations and financial position, planned products and services, business strategy
and plans, market size and growth opportunities, competitive position and market trends. Some of these forward-looking statements can
be identified by the use of forward-looking words, including “may,” “should,” “expect,” “intend,”
“will,” “estimate,” “anticipate,” “believe,” “predict,” “plan,”
“targets,” “projects,” “could,” “would,” “continue,” “forecast”
or the negatives of these terms or variations of them or similar expressions. For example, the Company is using forward-looking statements
in this press release when it discusses the expected proceeds, the intended use of proceeds, the expected initial closing date, the potential
for additional investments over a three year period, and that the strategic funding, once closed, is expected to provide the balance-sheet
strength and operational runway to scale its technology infrastructure at the exact moment global demand for sovereign cognitive defense
is surging. These statements relate to future events and involve known and unknown risks, uncertainties, and other factors which may cause
actual results, performance or achievements to be materially different from any future results, performance or achievements expressed
or implied by the forward-looking statements. Such factors include those set forth in Cyabra’s filings with the SEC. Prospective investors
are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. Cyabra
undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.